Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

  • SEC EDGAR•filings
    8-K - REPLIGEN CORP (0000730272) (Filer)

    Repligen Corp filed a Form 8-K on October 6, 2026, reporting completion of an acquisition or disposition of assets, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - BIOLIFE SOLUTIONS INC (0000834365) (Filer)

    Biolife Solutions Inc. filed a Form 8-K on Oct. 6, 2026 reporting an acquisition, a delisting notice and listing transfer, changes to security holder rights, control changes, director/officer departures and appointments, and amendments to its articles of incorporation.

  • SEC EDGAR•filings
    8-K - Paramount Skydance Corp (0002041610) (Filer)

    Paramount Skydance Corp filed an 8-K reporting entry into and termination of material definitive agreements, completion of an asset acquisition or disposition, creation of a direct financial obligation, unregistered equity sales, and changes to directors/officers with related compensation arrangements.

  • SEC EDGAR•filings
    8-K - Tenable Holdings, Inc. (0001660280) (Filer)

    Tenable Holdings, Inc. filed a Form 8-K on October 6, 2026, disclosing director and officer departures and appointments, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • Bank of England•monetary
    Minutes of the UK Money Markets Code Sub-Committee – September 2026

    The Bank of England released minutes from the September 2026 meeting of the UK Money Markets Code Sub-Committee, which provides a forum for market participants and authorities to discuss unsecured deposits, funding, securities lending and repo markets.

  • SEC EDGAR•filings
    8-K - Bluejay Diagnostics, Inc. (0001704287) (Filer)

    Bluejay Diagnostics, Inc. filed a Form 8-K on October 6, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - Clean Energy Fuels Corp. (0001368265) (Filer)

    Clean Energy Fuels Corp. filed a Form 8-K on Oct. 6, 2026, reporting director and officer departures, appointments, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • ECB•monetary
    Piero Cipollone: Money in the digital age: digital euro, tokenisation and the role of central banks

    ECB official Piero Cipollone discussed the digital euro, tokenisation of assets, and the role of central banks in the digital age.

  • ECB•monetary
    Frank Elderson: Effective supervision through timely remediation

    ECB member Frank Elderson highlighted that effective supervision requires timely remediation of identified issues.

  • SEC EDGAR•filings
    8-K - BION ENVIRONMENTAL TECHNOLOGIES INC (0000875729) (Filer)

    Bion Environmental Technologies Inc filed a Form 8-K on October 6, 2026, including Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits, with accompanying documents attached.

  • SEC EDGAR•filings
    8-K - GULF RESOURCES, INC. (0000885462) (Filer)

    Gulf Resources, Inc. filed a Form 8-K on October 6, 2026, reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.

  • SEC EDGAR•filings
    8-K - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Filer)

    Wheeler Real Estate Investment Trust, Inc. filed a Form 8-K on October 6, 2026 reporting unregistered sales of equity securities, material modifications to security holders’ rights, and other events.

  • SEC EDGAR•filings
    8-K - Blue Bird Corp (0001589526) (Filer)

    Blue Bird Corp filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation/off-balance-sheet arrangement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Curaleaf Holdings, Inc. (0001756770) (Filer)

    Curaleaf Holdings, Inc. filed a Form 8-K with the SEC on October 6, 2026 (Accession No. 0001104659-26-113907), including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - TPG RE Finance Trust, Inc. (0001630472) (Filer)

    TPG RE Finance Trust, Inc. filed an 8-K on October 6, 2026 reporting a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Worksport Ltd (0001096275) (Filer)

    Worksport Ltd filed a Form 8-K on October 6, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - POWERCOMPUTE, INC. (0001640384) (Filer)

    PowerCompute, Inc. filed a Form 8-K on October 6, 2026 reporting the termination of a material definitive agreement, including a Regulation FD disclosure and accompanying financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - SHF Holdings, Inc. (0001854963) (Filer)

    SHF Holdings, Inc. filed a Form 8-K on October 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Microbot Medical Inc. (0000883975) (Filer)

    Microbot Medical Inc. filed a Form 8-K on October 6, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - bioAffinity Technologies, Inc. (0001712762) (Filer)

    bioAffinity Technologies, Inc. filed a Form 8-K on October 6, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - AUDDIA INC. (0001554818) (Filer)

    Auddia Inc. filed a Form 8-K on October 6, 2026, reporting a submission of matters to a vote of security holders (Item 5.07), other events (Item 8.01), and accompanying financial statements and exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - RTB Digital, Inc. (0001419275) (Filer)

    RTB Digital, Inc. filed a Form 8-K on October 6, 2026 reporting the departure, election or appointment of certain directors and officers and related compensatory arrangements, and providing its financial statements and accompanying exhibits.

  • SEC EDGAR•filings
    8-K - Option Care Health, Inc. (0001014739) (Filer)

    Option Care Health, Inc. filed a Form 8-K on October 6 2026 reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Onar Holding Corp (0001682265) (Filer)

    Onar Holding Corp filed a Form 8-K reporting a material definitive agreement, changes to its board and officers, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - HUBSPOT INC (0001404655) (Filer)

    HubSpot Inc. filed a Form 8-K on October 6 2026, reporting results of operations and financial condition, costs associated with exit or disposal activities, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - MAIA Biotechnology, Inc. (0001878313) (Filer)

    MAIA Biotechnology, Inc. filed a Form 8-K on October 6, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - STRYKER CORP (0000310764) (Filer)

    Stryker Corp filed a Form 8-K on Oct. 6, 2026, reporting director/officer departures and appointments, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - INTERNATIONAL BANCSHARES CORP (0000315709) (Filer)

    International Bancshares Corp filed a Form 8-K on Oct 6, 2026, reporting a notice of delisting or failure to meet a continued listing rule and a transfer of listing, along with Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - ArriVent BioPharma, Inc. (0001868279) (Filer)

    ArriVent BioPharma, Inc. filed a Form 8-K on October 6, 2026 (Accession No. 0001104659-26-113898) containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - PDS Biotechnology Corp (0001472091) (Filer)

    PDS Biotechnology Corp filed a Form 8-K on October 6, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).